Propafenone Therapy

Propafenone Therapy is an antiarrhythmic treatment modality that belongs to the class of sodium channel-blocking pharmacological interventions and is distinguished by its use of propafenone, a class 1C antiarrhythmic agent, to suppress cardiac arrhythmias through voltage-dependent inhibition of fast sodium currents.

384

Publications

16.7K

Citations

1.5K

Authors

431

Institutions

Publications per year

2017–2026

15

Authors

1.5K

  1. JT
    Juan Tamargo

    Universidad Complutense de Madrid, Spain

    10 publications · 254 citations

    10

    h-index

  2. GF
    Gerhard F. Ecker

    University of Vienna, Austria

    10 publications · 434 citations

    10

    h-index

  3. GB
    Giuseppe Boriani

    University of Bologna, Italy

    9 publications · 799 citations

    9

    h-index

  4. PC
    Peter Chiba

    Medical University of Vienna, Austria

    9 publications · 421 citations

    9

    h-index

  5. EB
    Edward B. Kirsten

    Columbia University, United States

    7 publications · 172 citations

    7

    h-index

1–5 of 1.5K

Venues

  1. The American Journal of Cardiology

    56 publications · 3.4K citations

    37

    h-index

  2. Pacing and Clinical Electrophysiology

    PACE · 23 publications · 708 citations

    17

    h-index

  3. Journal of the American College of Cardiology

    JACC · 18 publications · 1.1K citations

    17

    h-index

  4. PubMed

    Repository · 34 publications · 738 citations

    17

    h-index

  5. American Heart Journal

    AHJ · 17 publications · 419 citations

    14

    h-index

1–5